Clínica Reñaca

Viña del Mar 2540488

0 studies enrolling now · 2 studies all time

What they study most

Acute Coronary Syndrome, Coronary Artery Disease, Myocardial Infarction, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Percutaneous Coronary Intervention

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early